News Image

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Provided By GlobeNewswire

Last update: Aug 31, 2025

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology

Read more at globenewswire.com

CYTOKINETICS INC

NASDAQ:CYTK (11/3/2025, 11:41:09 AM)

60.88

-2.71 (-4.26%)



Find more stocks in the Stock Screener

Follow ChartMill for more